Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients

Kidney Int. 2021 Dec;100(6):1337-1340. doi: 10.1016/j.kint.2021.09.014. Epub 2021 Oct 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Kidney Transplantation* / adverse effects
  • RNA, Messenger / genetics
  • SARS-CoV-2
  • T-Lymphocytes
  • Transplant Recipients

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • BNT162 Vaccine